Characteristics of the study cohort with respect to inhibitor status
. | Distribution by severity of hemophilia and inhibitor status, no. (%) . | . | . | . | ||
|---|---|---|---|---|---|---|
| Type of hemophilia A . | HR . | LR . | No inhibitor . | Total, no. . | ||
| Severe | 52 (41.9) | 11 (8.9) | 61 (49.2) | 124 | ||
| Moderate | 2 (7.7) | 5 (19.2) | 19 (73.1) | 26 | ||
| Mild | 3 (21.4) | 4 (28.6) | 7 (50.0) | 14 | ||
| Total | 57 (34.8) | 20 (12.2) | 87 (53.0) | 164 | ||
. | Distribution by severity of hemophilia and inhibitor status, no. (%) . | . | . | . | ||
|---|---|---|---|---|---|---|
| Type of hemophilia A . | HR . | LR . | No inhibitor . | Total, no. . | ||
| Severe | 52 (41.9) | 11 (8.9) | 61 (49.2) | 124 | ||
| Moderate | 2 (7.7) | 5 (19.2) | 19 (73.1) | 26 | ||
| Mild | 3 (21.4) | 4 (28.6) | 7 (50.0) | 14 | ||
| Total | 57 (34.8) | 20 (12.2) | 87 (53.0) | 164 | ||